Nexus of Pathophysiology and Therapeutics (NPT) is an international, peer-reviewed journal publishing research in pathophysiology, biomedical sciences, pharmacology, and therapeutics, with a focus on disease mechanisms and clinical applications.

 

Nexus of Pathophysiology and Therapeutics (NPT)

Connecting Disease Science, Clinical Evidence, and Therapeutic Innovation

Nexus of Pathophysiology and Therapeutics (NPT) is an international, peer-reviewed, open-access journal dedicated to advancing research across clinical and translational science, diagnostics, biomarkers, pathophysiology, disease biology, pharmacology, therapeutics, laboratory and biomedical sciences, immunology, inflammation, infectious diseases, toxicology, and natural products and therapeutic modulation.

NPT provides a multidisciplinary platform for research addressing the mechanisms, diagnosis, prognosis, prevention, monitoring, and treatment of human diseases and relevant experimental models, as well as the development and evaluation of therapeutic strategies and biomedical interventions.

A central focus of NPT is to connect disease biology and pathophysiology with diagnosis, pharmacological intervention, therapeutic development, and clinical application.

Our Mission

NPT aims to connect biomedical discovery with clinical application and therapeutic innovation by publishing rigorous, scientifically sound, and meaningful research that advances understanding of disease and contributes to improved approaches to diagnosis, prevention, monitoring, and treatment.

What We Publish

NPT welcomes high-quality original research, clinical and translational studies, diagnostic and biomarker research, experimental and mechanistic studies, observational research, systematic reviews, meta-analyses, narrative reviews, brief reports, methodological studies, research protocols, perspectives, commentaries, and editorials.

Research may address areas including:

  • Clinical and Translational Research

  • Diagnostics, Biomarkers, and Prognostic Research

  • Pathophysiology and Disease Biology

  • Pharmacology and Therapeutics

  • Immunology, Inflammation, and Infectious Diseases

  • Toxicology and Drug Safety

  • Natural Products and Therapeutic Modulation

  • Laboratory and Biomedical Sciences

  • Molecular, Cellular, and Experimental Research

  • Emerging Biomedical Technologies and Computational Approaches

NPT considers experimental, clinical, translational, prospective, retrospective, and observational studies when they address meaningful biomedical, diagnostic, prognostic, pharmacological, therapeutic, or disease-related questions.

For the complete scope of the journal, please see the Aims and Scope page.

Rigorous and Transparent Peer Review

Manuscripts undergo double-blind peer review and are normally evaluated by at least two independent external reviewers with appropriate subject expertise.

Each manuscript is assessed according to its study design and scientific objectives, with consideration of methodological rigor, scientific validity, originality, relevance, transparency, and the appropriate clinical, biological, diagnostic, pharmacological, therapeutic, or mechanistic contribution.

Read the full Editorial and Peer-Review Policy.

Publication Ethics and Research Integrity

NPT is committed to research integrity, publication ethics, editorial independence, transparency, and responsible scientific communication. The journal follows established principles and recommendations, including those of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).

Authors, reviewers, and editors are expected to comply with the journal's policies concerning authorship, conflicts of interest, research ethics, data integrity, peer-review confidentiality, artificial intelligence, corrections, retractions, and other aspects of responsible scholarly publishing.

Read the full Publication Ethics and Malpractice Policy.

Open Access

NPT is a fully open-access journal. All published articles are freely and immediately accessible to readers.

Articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated in the individual article.

Continuous Publication

NPT follows a continuous publication model. Articles are published online individually after completion of peer review, editorial processing, and production, allowing accepted research to become available without waiting for the completion of a conventional issue.

An International Scientific Community

NPT welcomes submissions from researchers and clinicians worldwide across medicine, pharmacy, pharmacology, biomedical sciences, laboratory sciences, biochemistry, molecular and cellular biology, pathophysiology, immunology, infectious diseases, toxicology, natural products, and related disciplines.

The journal is committed to maintaining an internationally diverse editorial community and encouraging scientific contributions from researchers across different geographical regions and research environments.

Journal Information

ISSN: 3116-0921
Publisher: Nexumed Scientific Press
Peer Review: Double-blind
Access Model: Fully Open Access
Publication Model: Continuous Publication
Language: English

NPT — Connecting Disease Science, Clinical Evidence, and Therapeutic Innovation.

 

Submit Manuscript | Guide for Authors | Aims and Scope